banner2

Getting started
4-(Chloromethyl)benzoyl Chloride

4-(Chloromethyl)benzoyl Chloride - China Manufacturers, Factory, Suppliers

4-(Chloromethyl)benzoyl Chloride, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

4-(Chloromethyl)benzoyl Chloride CAS 876-08-4 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — 4-(Chloromethyl)benzoyl Chloride CAS 876-08-4 Purity >98.0% (GC)
Read More

DL-2,3-Diaminopropionic Acid Hydrochloride CAS 54897-59-5 Assay 98.5-101.5% (Titration) Purity ≥99.0% (HPLC)

DL-Cysteine Hydrochloride CAS 10318-18-0 Assay 98.0%-102.0%

DL-Lysine Monohydrochloride CAS 70-53-1 Assay 98.0%-101.0% (Titration)

DL-Proline Methyl Ester Hydrochloride CAS 79397-50-5 Assay ≥98.0% (TLC)

DL-Serine Hydrazide Hydrochloride CAS 55819-71-1 Assay ≥98.0% (HPLC)

DL-Histidine Monohydrochloride Monohydrate CAS 123333-71-1 Assay 99.0%-101.0% (HPLC)

banner4

Top Selling Products

Related Blog
Reviews

The 3rd China International Biological & Chemical Pharmaceutical Industry Conference

The 3rd CMC-China 2021 Time: September 29-30, 2021 Exhibition Venue: C-D Hall, Suzhou International Expo Center, Suzhou City, JIangsu Province, China. Synergy of Centralized China’s Drug Volume-ba...
Xi presents award to top scientists

President Xi Jinping, also general secretary of the Communist Party of China (CPC) Central Committee and chairman of the Central Military Commission, presents China’s top science award to a...
Paxlovid: what we know about Pfizer's Covid-19 pill

Pfizer is seeking emergency use authorisation from the FDA for its novel Covid-19 antiviral pill Paxlovid. Share Article On the heels of Merck antiviral molnupiravir’s UK approval, Pfizer...
The 19th Beijing Conference and Exhibition on Instrumental Analysis (BCEIA 2021)-Shanghai Ruifu Chemical Co., Ltd. participated in the exhibition

The 19th Beijing Conference and Exhibition on Instrumental Analysis (BCEIA 2021) was held on September 27-29, 2021 at China International Exhibition Center (Tianzhu New Hall), Beijing. Adhering to...
The third Guangdong-Hong Kong-Macao Greater Bay Area Pharmaceutical Innovation Technology and Market Access Summit forum November 19 to 21, 2021

The third Guangdong-Hong Kong-Macao Greater Bay Area Pharmaceutical Innovation Technology and Market Access Summit forum November 19 to 21, 2021 As the world’s second largest medical market, ...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...

2022.10.25 07:41:30
2022.10.21 05:53:28
2022.09.09 15:56:43
2022.09.03 06:47:05
2021.12.19 02:49:50
2021.11.02 10:26:09

related search